The role of nitric oxide in the treatment of neonatal pulmonary hypertension

Current Opinion in Pediatrics

Volumn 8, Issue 2, 1996, Pages 118-125

  Mariani, Gonzalo ^a   Barefield, Elaine S ^a   Carlo, Waldemar A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

BLOOD OXYGENATION; CLINICAL TRIAL; CONGENITAL DIAPHRAGM HERNIA; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INOTROPISM; LUNG BLOOD FLOW; LUNG DYSPLASIA; LUNG INJURY; LUNG VENTILATION PERFUSION RATIO; METHEMOGLOBINEMIA; NEWBORN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; SEPSIS; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0029924288     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199604000-00006     Document Type: Review

References (80)

1. Morin FC, Stenmark KR: Persistent pulmonary hypertension of the newborn: Am J Respir Crit Car Med 1995, 151:2010-2032. Excellent state-of-art review article on several aspects of PPHN.
2. Stark AR, Davidson D: Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: implications and strategy for future "high-tech" neonatal clinical trials. Pediatrics 1995, 96:1147-1151. A summary of data concerning the clinical trials currently in progress.
3. Heymann J, Adams A, Gardner T: Persistent pulmonary hypertension of the newborn: trends, incidence, diagnosis, and management. Am J Dis Child 1984, 138:592-595.
4. Waish-Sukys MC, Cornell DJ, Houston LN, Keszler M, Kanto WP: Treatment of persistent pulmonary hypertension of the newborn without hyperventilation: an assessment of diffusion of innovation. Pediatrics 1994, 94:303-306. Results of a national survey about treatment practices for PPHN showing that the use of hyperventilation and rescue therapies have a higher prevalence than conservative ventilation.
5. Sahni R, Wung JT, James LS: Controversies in management of persistent pulmonary hypertension in the newborn. Pediatrics 1994, 94:307-309.
6. Bifano EM, Pfannenstiel A: Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics 1988, 81:657-661.
7. Wung JT, James LS, Kilchevsky E, James E: Management of infants with severe respiratory failure and persistence of fetal circulation. Pediatrics 1985, 76:488-494.
8. Clark RH, Yoder BA, Sell MS: Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 1994, 124:447-454.
9. Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL: Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 1991, 87:101-107.
10. Welch JC, Bridson JM, Gibbs JL: Endotracheal tolazoline for severe persistent pulmonary hypertension of the newborn. Br Heart J 1995, 73:99-100. Case report of a neonate with PPHN who had a dramatic improvement in oxygenation after endotracheal administration of tolazoline.
11. Kaapa P, Koivisto M, Ylikorkala O, Kouvalainen K: Prostacyclin in the treatment of neonatal pulmonary hypertension. J Pediatr 1985, 107:951-953.
12. Abu-Osba YK, Galal O, Manasra K, Reijal A: Treatment of severe pulmonary hypertension of the newborn with magnesium sulphate. Arch Dis Child 1992, 67:31-35.
13. Rhodes J, Wung J-T, Bierman FZ: Effect of blood pressure cuffs on neonatal circulation: their potential application to newborns with persistent pulmonary hypertension. Pediatr Cardiol 1995, 16:20-23. Describes the use of blood pressure cuffs to selectively increase peripheral resistance in neonates with PPHN (like medical antishock trousers).
14. DeLosh T: Neonatal ECMO Registry Of the Extracorporeal Lite Support Organization (ELSO). Ann Arbor, MI: Extracorporeal Life Support Organization; 1994.
15. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
16. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987, 84:9265-9269.
17. Abman SH, Chatfield BA, Hall SL, McMurty IF: Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990, 259:H1921-H1927.
18. Ziegler JW, Ivy DD, Kinsella JP, Abman HS: The role of nitric oxide, endothelin, and prostaglandins in the transition of the pulmonary circulation. Clin Perinatol 1995, 22:387. Thorough and up-to-date review of the factors involved in the changes in pulmonary circulation in the perinatal period.
19. Steinhorn RH, Millard SL, Morin FC: Persistent pulmonary hypertension of the newborn: role of nitric oxide and endothelin in pathophysiology and treatment. Clin Perinatol 1995, 22:405-428. Complete review of the pathophysiology of PPHN, with special emphasis on endothelin and nitric oxide.
20. Vosatka RJ, Kashyap S, Trifiletti RR: Arginine deficiency accompanies persistent pulmonary hypertension of the newborn. Biol Neonate 1994, 66:65-70. Arginine plasma levels are lower in neonates with PPHN than in control subjects. Levels of all the other amino acids are comparable. Arginine levels increase after parenteral nutrition is started.
21. Castillo L, DeRojas-Walker T, Yu YM, Sanchez M, Chapman TE, Shannon D, Tannenbaum S, Burke JF, Young VR: Whole body arginine metabolism and nitric oxide synthesis in newborns with persistent pulmonary hypertension. Pediatr Res 1995, 38:17-24. First demonstration of decreased arginine utilization for whole-body NO synthesis during the acute vasoconstrictive state of PPHN.
22. Block ER, Herrera H: Hypoxia inhibits L-arginine uptake by pulmonary artery endoethelial cells [abstract]. Am J Respir Crit Care Med 1994, 149:A21.
23. Dollberg S, Warner BW, Myatt L: Urinary nitrite and nitrate concentrations in patients with idiopathic persistent pulmonary hypertension of the newborn and effect of extracorporeal membrane oxygenation. Pediatr Res 1995, 37:31-34. Nitrite and nitrate urinary levels are decreased in patients with PPHN during the acute phase of the disease. Increasing oxygenation from ECMO or from resolution of PPHN is associated with increased NO synthesis.
24. Abman SH: Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension. Curr Opin Pediatr 1994, 239-247.
25. Edwards AD: The pharmacology of inhaled nitric oxide. Arch Dis Child 1995, 72:F127-F130.
26. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Barker JR, Matalon S: Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 1993, 265:L555-L564.
27. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications of endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990, 87:1620-1624.
28. Centers for Disease Control: Recommendations for occupational safety and health standards. MMWR Morbid Mortal Wkly Rep 1988, 37:21.
29. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ: Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child 1994, 70:F47-F49.
30. Lunn RJ: Inhaled nitric oxide. Mayo Clin Proc 1995, 70:247-255. Excellent review of the basic science, physiology, and delivery of NO.
31. Scott EM, Hoskins DD: Hereditary methemoglobinemia in Alaskan Eskimos and Indians. Blood 1958, 13:795-802.
32. Hogman M, Frostell C, Arnberg H, Sandhagen B, Hedenstierna G: Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand 1994, 151:125-129.
33. Hogman M, Frostell C, Arnberg H, Sandhagen B, Hedenstierna G: Bleeding time prolongation and NO inhalation. Lancet 1993, 341:1664-1665.
34. Watkins SC, Haltler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992, 120:227-237.
35. Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, Fifer MA: Hemodynamic effects of INO in heart failure. J Am Coll Cardiol 1994, 24:982-988.
36. Wessel DL, Adatia I, Thompson JE, Hickey PR: Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 1994, 22:930-938. Description of an adaptable system to deliver NO in various clinical settings and the results of its use among 132 patients of different ages with pulmonary hypertension.
37. Milner AD, Aiton N: Nitric oxide inhalation [editorial]. Pediatr Pulmonol 1995, 11:100-101. Succinct editorial about technical and practical aspects of NO inhalation.
38. 2 prior to their clinical application.
39. Petros AJ, Cox P, Bohn D: A simple method for monitoring the concentration of inhaled nitric oxide. Anesthesia 1944, 49:317-319.
40. Rogers NE, Ignarro LJ: Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun 1992, 189:242-249.
41. Frostell C, Fratacci M-D, Wain J, Jones R, Zapol WM: Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991, 83:2038-2047.
42. Fratacci M-D, Frostell CG, Chen T-Y, Wain JC, Robinson DR, Zapol WM: Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991, 75:990-999.
43. Zayek M, Cleveland D, Morin FC: Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J Pediatr 1993, 122:743-750.
44. McQueston JA, Kinsella JP, Ivy DD, Abman SH: Chronic intrauterine pulmonary hypertension impairs endothelium-dependent vasodilation in fetal lambs. Am J Physiol 1995, 268:H288-294.
45. Pepke-Zaba J, Higenbottan TW, Dinh-Xuan T, Stone D, Wallwork J: Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991, 338:1173-1174.
46. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993, 328:399-405.
47. Roberts JD, Polaner DM, Lang P, Zapol WM: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992, 340:818-819.
48. Kinsella JP, Neish SR, Shaffer E, Abman SH: Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992, 340:819-820.
49. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abram SH: Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 1993, 123:103-108.
50. Kinsella JP, Abman SH: Efficacy of inhalational nitric oxide therapy in the clinical management of persistent pulmonary hypertension of the newborn. Chest 1994, 105:925-945.
51. Bührer C, Merker G, Falke K, Versmold H, Obladen M: Dose-response to inhaled nitric oxide in acute hypoxemic respiratory failure of newborn infants: a preliminary report. Pediatr Pulmonol 1995, 19:291-298. Ten hypoxemic infants received increasing doses of NO up to 80 ppm. The rate of response was low; the optimal NO concentration varied among patients and showed temporal variations. The response to NO was similar with conventional and high-frequency oscillatory ventilation.
52. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA: Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 1994, 124:302-308.
53. Rozé J-C, Storme L, Zupan V, Morville P, Dinh-Xuan AT, Mercier J-C: Echocardiographic investigation of inhaled nitric oxide in newborn babies with severe hypoxia. Lancet 1994, 344:303-305.
54. Lönnqvist PA, Winberg P, Lundell B, Selldén H, Olsson GL: Inhaled nitric oxide in neonates and children with pulmonary hypertension. Acta Pediatr 1994, 83:1132-1136. The authors report on fourteen pediatric patients with pulmonary hypertension treated with inhaled NO. Overall, one third had a substantial response to oxygenation, one third had an undesirable response, and one third had no response in terms of improvement.
55. Karamanoukian HL, Glick PL, Zayek M, Steinhorn RH, Zwass MS, Fienman JR, Morin FC: Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics 1994, 94:715-718. A lack of response to inhaled NO in nine patients with PPHN secondary to pulmonary hypoplasia (eight with CDH) was reported. All patients went to ECMO. Five infants in whom pulmonary hypertension recurred after ECMO did respond to NO inhalation.
56. Shah N, Jacob T, Exler R, Morrow S, Ford H, Albanese C, Wiener E, Rowe M, Billiar T, Simmons R, et al.: Inhaled nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg 1994, 29:1010-1014.
57. Peliowski A, Finer NN, Etches PC, Tierney AJ, Ryan CA: Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. J Pediatr 1995, 126:450-453. Reports on eight preterm infants with signs of PPHN who received inhaled NO with positive response.
58. Abman SH, Kinsella JP, Schaffer MS, Walkening RB: Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 1993, 92:606-609.
59. Kinsella JP, Schmidt JM, Abman SH: Inhaled nitric oxide treatment for stabilization and emergency medical transport of critically ill newborns and infants. Pediatrics 1995, 95:773-776.
60. Barefield ES, Karle VA, Philips JB III, Carlo WA: Randomized, controlled trial of inhaled nitric oxide in ECMO candidates [abstract]. Pediatr Res 1995, 37:195A.
61. Storme L, Francoise M, Tahiri C, Zupan V, Rozé JC, Oriot D, Galperine I, Mercier JC, the French NO Study Group: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn [abstract]. Pediatr Res 1994, 35:60A.
62. Waffarn F, Turbow R, Yang L, Sills J, Hallman M: Treatment of persistent pulmonary hypertension of the newborn: a randomized trial comparing intermitent mandatory ventilation and high frequency oscillatory ventilation for delivering nitric oxide [abstract]. Pediatr Res 1995, 37:243A.
63. Short BL, Asay G, Rivera O, Martin G, Fernandez P, Rais-Bahrami K: Inhaled nitric oxide: not an effective rescue therapy for severe respiratory failure in the newborn infant [abstract]. Proceedings of the 10th Annual ECMO Symposium, Keystone, CO; 1994:4A.
64. Turbow R, Waffarn F, Yang L, Sills J, Hallman M: Variable oxygenation response to inhaled nitric oxide in severe persistent pulmonary hypertension of the newborn. Acta Paediatr 1995, 84:1305-1308. Thirteen consecutive neonates with severe PPHN were treated with inhaled NO at doses of 20 ppm or less. Responses were rapid in six patients, intermediate in three, delayed in three, and absent in one.
65. Day RW, Lynch JM, White KS, Ward RM: Inhaled nitric oxide in newborns with pulmonary hypertension: the radiographic severity of lung disease corresponds with the degree of acute improvement in systemic oxygenation. Pediatr Res 1995, 37:25A.
66. Steinhorn RH, Cox PN, Fineman JR, Zwass MC, Morin FC III: A response to inhaled nitric oxide does not predict survival in persistent pulmonary hypertension of the newborn due to alveolar capillary dysplasia [abstract]. Pediatr Res 1994, 35:257A.
67. Walther FJ, Benders MJ, Leighton JO: Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics 1992, 90:899-904.
68. Mupanemunda RH, Silverman M: Inhaled nitric oxide in respiratory distress syndrome [abstract]. Pediatr Res 1994, 35:346A.
69. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ: Use of inhaled nitric oxide and acetylcholine in the resolution of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993, 88:2128-2138.
70. Miller VM, Aarhus LL, Vanhoutte PM: Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol 1986, 251:H520-H527.
71. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ: Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994, 108:487-494.
72. Journois D, Pouard P, Mauriat P, Malhere T, Vouhé P, Safran D: Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994, 107:1129-1135.
73. Beghetti M, Habre W, Friedli B, Berner M: Continuous low pulmonary hypertension after cardiac surgery in pediatric patients. Br Heart J 1995, 73:65-68. Six of seven pediatric patients with postoperative pulmonary hypertension had a marked improvement in oxygenation following inhaled NO administration. Early NO weaning failed and they received NO treatment for up to 16 days, with resolution of the pulmonary hypertension.
74. Schranz D, Huth R, Wippermann C-F, Ritzerfield S, Schmitt FX, Oelert H: Nitric oxide and prostacyclin lower suprasystemic pulmonary hypertension after cardiopulmonary bypass. Eur J Pediatr 1993, 152:793-796.
75. Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM: Inhaled nitric oxide in congestive heart disease. Circulation 1993, 87:447-453.
76. Goodman G, Perkin RM, Anas NG, Sperling DR, Hicks DA, Rowen M: Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1988, 112:67-72.
77. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP: Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994, 124:881-888.
78. Mupanemunda RH, Silverman M: Low-dose inhaled nitric oxide in infants with bronchopulmonary dysplasia [abstract]. Pediatr Res 1994, 36:31A.
79. Leclerce F, Riou Y, Martinot A, Storme L, Hue V, Flurin V, Deschildre A, Sadik A: Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia. Intensive Care Med 1994, 20:511-512.
80. Thompson MW, Bates JN, Klein JM: Treatment of respiratory failure in an infant with bronchopulmonary dysplasia infected with respiratory syncytial virus using inhaled nitric oxide and high frequency ventilation. Acta Paediatr 1995, 84:100-102.